Literature DB >> 25336553

Mesenteric vein thrombosis caused by secondary polycythaemia from AndroGel.

Heather Katz1, Eugene Popov1, Natasha Bray1, Barry Berman2.   

Abstract

Mesenteric vein thrombosis is a rare but potentially lethal cause of abdominal pain. It is usually caused by prothrombotic states that can either be hereditary or acquired. Testosterone supplementation causes an acquired prothrombotic state by promoting erythropoeisis thus causing a secondary polycythaemia. We report a case of a 59-year-old man with a history of chronic obstructive pulmonary disease (COPD) stage III, who presented with abdominal pain. Evaluation revealed an elevated haemoglobin and haematocrit, a superior mesenteric vein thrombosis on CT and a negative Janus kinase 2 mutation. The patient is currently being treated with 6 months of anticoagulation with rivaroxiban. Although a well-known side effect of testosterone is thrombosis, the present case is used to document in the literature the first case of mesenteric vein thrombosis due to secondary polycythaemia from Androgel in the setting of COPD. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25336553      PMCID: PMC4208124          DOI: 10.1136/bcr-2014-206023

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  11 in total

1.  Reversal of polycythaemia induced by intramuscular androgen replacement using transdermal testosterone therapy.

Authors:  H Siddique; J C Smith; R J M Corrall
Journal:  Clin Endocrinol (Oxf)       Date:  2004-01       Impact factor: 3.478

Review 2.  Mesenteric venous thrombosis.

Authors:  Ian G Harnik; Lawrence J Brandt
Journal:  Vasc Med       Date:  2010-10       Impact factor: 3.239

Review 3.  Diagnosis of acute abdominal pain in older patients.

Authors:  Corey Lyon; Dwayne C Clark
Journal:  Am Fam Physician       Date:  2006-11-01       Impact factor: 3.292

Review 4.  Mesenteric venous thrombosis.

Authors:  Ashwani K Singal; Patrick S Kamath; Ayalew Tefferi
Journal:  Mayo Clin Proc       Date:  2013-02-27       Impact factor: 7.616

5.  Effects of graded doses of testosterone on erythropoiesis in healthy young and older men.

Authors:  Andrea D Coviello; Beth Kaplan; Kishore M Lakshman; Tai Chen; Atam B Singh; Shalender Bhasin
Journal:  J Clin Endocrinol Metab       Date:  2007-12-26       Impact factor: 5.958

6.  Prevalence of venous thromboembolism in patients with secondary polycythemia.

Authors:  Omar Nadeem; Jiang Gui; Deborah L Ornstein
Journal:  Clin Appl Thromb Hemost       Date:  2012-09-23       Impact factor: 2.389

7.  Control of breathing in patients with chronic obstructive lung diseases and secondary polycythemia after venesection.

Authors:  D A Patakas; P I Christaki; G E Louridas; B J Sproule
Journal:  Respiration       Date:  1986       Impact factor: 3.580

Review 8.  Hypoxemia in patients with COPD: cause, effects, and disease progression.

Authors:  Brian D Kent; Patrick D Mitchell; Walter T McNicholas
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2011-03-14

Review 9.  Safety and efficacy of testosterone gel in the treatment of male hypogonadism.

Authors:  Kishore M Lakshman; Shehzad Basaria
Journal:  Clin Interv Aging       Date:  2009-11-18       Impact factor: 4.458

Review 10.  Risks of testosterone replacement therapy in men.

Authors:  E Charles Osterberg; Aaron M Bernie; Ranjith Ramasamy
Journal:  Indian J Urol       Date:  2014-01
View more
  1 in total

1.  Antiphospholipid syndrome presenting as acute mesenteric venous thrombosis involving a variant inferior mesenteric vein and successful treatment with rivaroxaban.

Authors:  Kevin Singh; Gulam Khan
Journal:  BMJ Case Rep       Date:  2018-03-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.